Wells Fargo & Company Annexon, Inc. Transaction History

Wells Fargo & Company

$410 Billion
Q1 2024

A detailed history of Wells Fargo & Company transactions in Annexon, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 28,905 shares of ANNX stock, worth $162,735. This represents 0.0% of its overall portfolio holdings.

Number of Shares

28,905

Previous 16,432 75.91%

Holding current value

$162,735

Previous $74,000 179.73%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$4.03 - $7.81 $50,266 - $97,414	12,473 Added 75.91%	28,905 $207,000
Q4 2023 Feb 09, 2024	BUY	$1.63 - $4.63 $8,498 - $24,140	5,214 Added 46.48%	16,432 $74,000
Q3 2023 Nov 13, 2023	SELL	$2.13 - $3.84 $13,127 - $23,665	-6,163 Reduced 35.46%	11,218 $26,000
Q2 2023 Aug 15, 2023	BUY	$2.1 - $6.37 $35,918 - $108,952	17,104 Added 6174.73%	17,381 $61,000
Q1 2023 May 12, 2023	BUY	$3.74 - $7.46 $18 - $37	5 Added 1.84%	277 $1,000

Q4 2022 Feb 13, 2023	BUY	$4.56 - $6.02 $27 - $36	6 Added 2.26%	272 $1,000
Q3 2022 Nov 14, 2022	BUY	$3.75 - $6.63 $348 - $616	93 Added 53.76%	266 $2,000
Q2 2022 Aug 12, 2022	SELL	$2.11 - $4.06 $5,625 - $10,823	-2,666 Reduced 93.91%	173 $1,000
Q1 2022 May 16, 2022	SELL	$2.73 - $11.94 $30,529 - $133,525	-11,183 Reduced 79.75%	2,839 $8,000
Q4 2021 Feb 14, 2022	BUY	$11.49 - $22.0 $159,837 - $306,042	13,911 Added 12532.43%	14,022 $161,000
Q2 2021 Aug 16, 2021	SELL	$17.81 - $27.48 $67,891 - $104,753	-3,812 Reduced 97.17%	111 $2,000
Q1 2021 May 13, 2021	SELL	$22.0 - $35.01 $171,688 - $273,218	-7,804 Reduced 66.55%	3,923 $109,000
Q4 2020 Feb 09, 2021	BUY	$20.81 - $30.55 $13,797 - $20,254	663 Added 5.99%	11,727 $294,000
Q3 2020 Nov 05, 2020	BUY	$17.5 - $30.23 $193,620 - $334,464	11,064 New	11,064 $334,000

Others Institutions Holding ANNX

# of Institutions

140

Shares Held

87.5M

Call Options Held

2.54M

Put Options Held

556K

View Full List

About Annexon, Inc.

Ticker ANNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,617,700
Market Cap $268M
Description
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...

More about ANNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Annexon, Inc. Transaction History